News – Page 1071 – Endpoints News

SIGN UP

Roche shares surge as a double-shot win in I/O and hemophilia raises blockbuster expectations

8 years ago

Fearless: Julian Adams looks to steer Gamida Cell through PhIII, an IPO and a market launch

8 years ago

ScPharmaceuticals raises $90M in IPO with heart failure drug on deck

8 years ago

UK research campus expands; FDA clears NGS test for tumors; Orphazyme raises €80 million IPO

8 years ago

Pfizer reshuffles top ranks with Albert Bourla as COO; Intra-cellular nabs Novartis vet Andrew Satlin as CMO

8 years ago

Annalisa Jenkins' next career chapter takes her back to Europe

8 years ago

A go-go FDA is opening up the fast lane to regenerative med approvals

8 years ago

Struggling Oncolytics Biotech signs $86.6M Asia deal with China's Adlai Nortye

8 years ago

Booming Regeneron gets the green light for a major expansion

8 years ago

What's a successful failure? Atlas' Booth sounds taps for Merck-backed Quartet Medicine

8 years ago

FDA clears next-gen tumor sequencing test from Memorial Sloan Kettering

8 years ago

The Pentagon's compromise: drug approvals to remain in FDA's hands

8 years ago

In blow to Shire, Roche bags an FDA OK for its blockbuster hemophilia A prospect

8 years ago

Merck partners up on T-cell tech platform in $374M autoimmune deal; Turnstone taps BMS vet Mike Burgess for top R&D ...

8 years ago

Let the jousting begin: Which top biopharma companies are looking to make a splash at ASH?

8 years ago

Arsanis prices $40M IPO for infectious disease work

8 years ago

FDA, EMA put a star CAR-T from bluebird and Celgene on the VIP list

8 years ago

X4 raises $27M to take Sanofi’s old drug through pivotal trial

8 years ago

Johns Hopkins has $65M to spend on taking their drugs right up to human studies

8 years ago

J&J goes back to Ionis for its second experimental pill for a GI autoimmune disease

8 years ago

You want to charge $1M for that gene therapy? Here’s where you’re wrong

8 years ago

Not your mom’s probiotic: GV-backed Evelo teams up with Mayo Clinic on microbiome drugs

8 years ago

Ultragenyx lands first FDA OK, with another on the horizon in shift to commercial ops

8 years ago

Moderna kicks off mRNA cancer vaccine study; Biotech stocks were checked this month -- but that's a good thing

8 years ago

First page Previous page 1068 1069 107010711072 1073 1074 Next page Last page